FDA Approves Unknown Drug — AMNEAL

# FDA Approves Amneal Generic Drug Application Amneal Pharmaceuticals received FDA approval for ANDA213562 on January 31, 2023, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceutical sector. The approval strengthens Amneal's pipeline and provides new revenue opportunities as it continues to build its presence across multiple therapeutic categories.